How M.D. was paid
$1.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| William Chou, M.D.President, Chief Executive Officer and Director | $660,985 | $239,266 | $334,972 | $234,040 | $17,500 | $1,486,763 |
| Kathleen BorthwickChief Financial Officer | $450,627 | $85,440 | $181,252 | $117,020 | $17,500 | $851,839 |
| Edgar B. (Chip) CaleGeneral Counsel and Corporate Secretary | $221,860 | $156,850 | — | $197,080 | $17,500 | $593,290 |
What changed and why
- $1.5MCEO total compensation decreased to $1,486,763 from $1,636,770 due to lower stock awards.
- 3.5%Base salaries for continuing officers increased by 3.5% to 7% in 2025.
- $234KDr. Chou received a non-equity incentive bonus of $234,040 based on performance objectives.
- Pearl Meyer evaluated executive compensation and established a peer group of twenty biopharmaceutical companies.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.